高级检索
当前位置: 首页 > 详情页

Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Hebei Med Univ, Hosp 4, Hebei Prov Canc Inst, Shijiazhuang, Hebei Province, Peoples R China
出处:
ISSN:

关键词: Programmed death-1 polymorphism risk prognosis esophageal squamous cell carcinoma

摘要:
Programmed death-1 (PD-1) is an immunoinhibitory receptor belonging to the CD28 family. This study was designed to investigate the association of PD-1 rs36084323:A>G, rs2227981:C>T, rs2227982:C>T and rs10204525:A>G single nucleotide polymorphisms (SNPs) with the risk and prognosis of esophageal squamous cell carcinoma (ESCC) in a high-incidence population from Northern China. These four SNPs were genotyped by polymerase chain reaction ligase detection reaction (PCR-LDR) method in 584 ESCC patients and 585 healthy controls. The rs2227981:C>T SNP C/T genotype increased the risk of ESCC for the smokers (OR = 1.483, 95% Cl = 1.018-2.160) and rs2227982:C>T SNP UT genotype enhanced susceptibility to ESCC for the females (OR = 1.708, 95% Cl = 1.056-2.762). For rs10204525:A>G SNP, A/A genotype was related to increased risk of ESCC (OR = 1.735, 95% CI = 1.086-2.771) overall. Among the 584 ESCC patients, the survival information of 204 ESCC patients was collected. The rs36084323:A>G SNP A/G genotype was associated with lower risk of death in ESCC patients with upper gastrointestinal cancer (UGIC) family history (HR = 0.339, 95%Cl = 0.115-0.996). The rs2227982:C>T SNP C/T genotype was associated with lower risk of death in smoker ESCC patients and ESCC patients with UGIC family history (HR = 0.409 and 0.292, 95%Cl = 0.194-0.863 and 0.101-0.847). PD-1 rs2227981:C>T, rs2227982:C>T and rs10204525:A>G SNPs might be used as predictive markers of the susceptibility to ESCC for the Han nationality in a high-incidence population from Northern China. PD-1 rs36084323:A>G and rs2227982:C>T SNPs were associated with the prognosis of the Han ESCC patients in this high-incidence region.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 4 区 遗传学 4 区 肿瘤学
最新[2025]版:
大类 | 4 区 医学
小类 | 4 区 遗传学 4 区 肿瘤学
JCR分区:
出版当年[2016]版:
Q3 GENETICS & HEREDITY Q3 ONCOLOGY
最新[2024]版:
Q3 GENETICS & HEREDITY Q3 ONCOLOGY

影响因子: 最新[2024版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Hebei Med Univ, Hosp 4, Hebei Prov Canc Inst, Shijiazhuang, Hebei Province, Peoples R China
通讯作者:
通讯机构: [1]Hebei Med Univ, Hosp 4, Hebei Prov Canc Inst, Shijiazhuang, Hebei Province, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:42329 今日访问量:0 总访问量:1365 更新日期:2025-08-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司 地址:河北省石家庄市健康路12号